248 related articles for article (PubMed ID: 29214586)
1. Epidemiology of Rare Lung Diseases: The Challenges and Opportunities to Improve Research and Knowledge.
McCarthy C; Lara Gallego B; Trapnell BC; McCormack FX
Adv Exp Med Biol; 2017; 1031():419-442. PubMed ID: 29214586
[TBL] [Abstract][Full Text] [Related]
2. Orphan Lung Diseases.
Ali MS; Ghori UK; Musani AI
Med Clin North Am; 2019 May; 103(3):503-515. PubMed ID: 30955517
[TBL] [Abstract][Full Text] [Related]
3. Perspectives for improving the evaluation and access of therapies for rare lung diseases in Europe.
Luisetti M; Balfour-Lynn IM; Johnson SR; Miravitlles M; Strange C; Trapnell BC; van Bronswijk H; Vogelmeier C
Respir Med; 2012 Jun; 106(6):759-68. PubMed ID: 22414566
[TBL] [Abstract][Full Text] [Related]
4. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
Groft SC; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
[TBL] [Abstract][Full Text] [Related]
5. [Rare lung diseases].
Paone G; Toti S; Salvati F
Recenti Prog Med; 2014 Sep; 105(9):341-50. PubMed ID: 25229763
[TBL] [Abstract][Full Text] [Related]
6. Rare diffuse diseases of the lung. Pulmonary alveolar proteinosis, lymphangioleiomyomatosis, amyloidosis.
Morbini P; Guddo F; Contini P; Luisetti M; Schiavina M; Zompatori M
Pathologica; 2010 Dec; 102(6):547-56. PubMed ID: 21428118
[TBL] [Abstract][Full Text] [Related]
7. Rare pulmonary diseases: a common fight.
Harari S; Humbert M
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877977
[TBL] [Abstract][Full Text] [Related]
8. [Rare diseases in pulmonary medicine and its challenges].
Wencker M; Teschler H; Vogelmeier C; Koczulla R
Pneumologie; 2012 Jul; 66(7):437-41. PubMed ID: 22692970
[TBL] [Abstract][Full Text] [Related]
9. Rare lung disease research: strategies for improving identification and recruitment of research participants.
Gupta S; Bayoumi AM; Faughnan ME
Chest; 2011 Nov; 140(5):1123-1129. PubMed ID: 22045877
[TBL] [Abstract][Full Text] [Related]
10. [Rare pulmonary diseases: from the adoption of orphan diseases to structured healthcare networks].
Cottin V; Cordier JF
Rev Mal Respir; 2014 Dec; 31(10):889-92. PubMed ID: 25465349
[No Abstract] [Full Text] [Related]
11. Preparing Data at the Source to Foster Interoperability across Rare Disease Resources.
Roos M; López Martin E; Wilkinson MD
Adv Exp Med Biol; 2017; 1031():165-179. PubMed ID: 29214571
[TBL] [Abstract][Full Text] [Related]
12. The importance of effective registries in pulmonary diseases and how to optimize their output.
Chorostowska-Wynimko J; Wencker M; Horváth I
Chron Respir Dis; 2019; 16():1479973119881777. PubMed ID: 31645111
[TBL] [Abstract][Full Text] [Related]
13. Respiratory diseases registries in the national registry of rare diseases.
Lara Gallego B; Abaitua Borda I; Galán Gil G; Castillo Villegas D; Casanova Espinosa Á; Cano Jiménez E; Ojanguren Arranz I; Posada de la Paz M
Arch Bronconeumol; 2014 Sep; 50(9):397-403. PubMed ID: 24703816
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis.
Kinder B; McCormack FX
Lymphat Res Biol; 2010 Mar; 8(1):71-9. PubMed ID: 20235889
[TBL] [Abstract][Full Text] [Related]
15. The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform.
Nurok M; Eslick I; Carvalho CR; Costabel U; D'Armiento J; Glanville AR; Harari S; Henske EP; Inoue Y; Johnson SR; Lacronique J; Lazor R; Moss J; Ruoss SJ; Ryu JH; Seyama K; Watz H; Xu KF; Hohmann EL; Moss F
Lymphat Res Biol; 2010 Mar; 8(1):81-7. PubMed ID: 20235890
[TBL] [Abstract][Full Text] [Related]
16. Rare lung diseases I--Lymphangioleiomyomatosis.
Juvet SC; Hwang D; Downey GP
Can Respir J; 2006 Oct; 13(7):375-80. PubMed ID: 17036091
[TBL] [Abstract][Full Text] [Related]
17. Focusing on rare diseases in China: are we there yet?
Yang L; Su C; Lee AM; Bai HX
Orphanet J Rare Dis; 2015 Nov; 10():142. PubMed ID: 26525984
[TBL] [Abstract][Full Text] [Related]
18. Establishing Patient Registries for Rare Diseases: Rationale and Challenges.
Boulanger V; Schlemmer M; Rossov S; Seebald A; Gavin P
Pharmaceut Med; 2020 Jun; 34(3):185-190. PubMed ID: 32215853
[TBL] [Abstract][Full Text] [Related]
19. Controversies and Evolving Concepts in Orphan Lung Diseases.
Gupta N; Ryu JH
Semin Respir Crit Care Med; 2020 Apr; 41(2):175-176. PubMed ID: 32279288
[No Abstract] [Full Text] [Related]
20. The world of rare interstitial lung diseases.
Buschulte K; Cottin V; Wijsenbeek M; Kreuter M; Diesler R
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36754433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
